Attachments
PDF
Share price & Turnover
-11.17%
|
0.26 MSEK
Share price change and turnover during the day of this press release
Calendar
| 2025-02-18 | Year-end Report 2024 |
| 2024-11-19 | Quarterly Report 2024-Q3 |
| 2024-08-20 | Quarterly Report 2024-Q2 |
| 2024-06-07 | Ex-date Ordinary Dividend CALMA B 0.00 SEK |
| 2024-06-05 | Annual General meeting |
| 2024-05-21 | Quarterly Report 2024-Q1 |
| 2024-02-20 | Year-end Report 2023 |
| 2023-12-14 | Extra General Meeting 2023 |
| 2023-11-21 | Quarterly Report 2023-Q3 |
| 2023-08-22 | Quarterly Report 2023-Q2 |
| 2023-05-23 | Quarterly Report 2023-Q1 |
| 2023-05-17 | Ex-date Ordinary Dividend CALMA B 0.00 SEK |
| 2023-05-16 | Annual General meeting |
| 2023-02-21 | Year-end Report 2022 |
| 2022-11-22 | Quarterly Report 2022-Q3 |
| 2022-09-22 | Extra General Meeting 2022 |
| 2022-08-23 | Quarterly Report 2022-Q2 |
| 2022-05-24 | Quarterly Report 2022-Q1 |
| 2022-05-19 | Ex-date Ordinary Dividend CALMA B 0.00 SEK |
| 2022-05-17 | Annual General meeting |
| 2022-02-25 | Year-end Report 2021 |
| 2022-02-23 | Year-end Report 2021 |
| 2021-10-29 | Quarterly Report 2021-Q3 |
| 2021-08-27 | Quarterly Report 2021-Q2 |
| 2021-05-28 | Quarterly Report 2021-Q1 |
| 2021-05-19 | Ex-date Ordinary Dividend CALMA B 0.00 SEK |
| 2021-05-18 | Annual General meeting |
| 2021-02-26 | Year-end Report 2020 |
| 2020-12-23 | Extra General Meeting 2020 |
| 2020-11-25 | Quarterly Report 2020-Q3 |
| 2020-08-27 | Quarterly Report 2020-Q2 |
| 2020-05-20 | Quarterly Report 2020-Q1 |
| 2020-05-15 | Ex-date Ordinary Dividend CALMA B 0.00 SEK |
| 2020-05-14 | Annual General meeting |
| 2020-02-28 | Year-end Report 2019 |
| 2019-11-25 | Quarterly Report 2019-Q3 |
| 2019-11-06 | Extra General Meeting 2019 |
| 2019-08-27 | Quarterly Report 2019-Q2 |
| 2019-05-23 | Quarterly Report 2019-Q1 |
| 2019-05-10 | Ex-date Ordinary Dividend CALMA B 0.00 SEK |
| 2019-05-09 | Annual General meeting |
| 2019-02-28 | Year-end Report 2018 |
| 2018-11-26 | Quarterly Report 2018-Q3 |
| 2018-08-27 | Quarterly Report 2018-Q2 |
Description
| Country | Sweden |
|---|---|
| List | Spotlight |
| Sector | Health care |
| Industry | Medical technology |
2022-08-24 11:57:55
Calmark Sweden AB:s testkassett för bilirubin har nu erhållit registrering av vietnamesiska myndigheter. Instrumentet, POC- Analyzer Neo, erhöll registrering den 10 augusti.
Dagens besked innebär att Calmarks Neo-produkt för bilirubin är färdigregistrerad och försäljning i Vietnam kan starta.
För mer information om Calmark Sweden AB, vänligen kontakta:
Anna Söderlund, VD
Telefon: +46 70 214 98 93
E-post: anna.soderlund@calmark.se
www.calmark.se